The Philadelphia drug injury lawyers at Feldman & Pinto are evaluating GranuFlo drug injury cases from people harmed by GranuFlo side effects.
The drug maker stated in a 2011 internal memo that GranuFlo and a similar product, Naturalyte, were associated with 914 cases of cardiac arrest. The memo also stated that Fresenius’s medical staff had concluded that GranuFlo caused a six-fold increase in the risk of cardiac arrest.
Use of these products can cause metabolic alkalosis, which can lead to:
- low blood pressure
- cardiac arrhythmia
- cardiac arrest
- stroke, and
- sudden death
In 2012 the FDA issued a class one recall of GranuFlo and the related product as a result of these risks. Despite knowledge of these risks, Fresenius continued to market these dangerous products to dialysis clinics and patients.
GranuFlo lawsuits brought against the manufacturer allege that the company:
- produced a dangerous and defective product
- knew about the serious risks associated with GranuFlo
- failed to adequately warn doctors and consumers of these risks, and
- intentionally withheld knowledge of GranuFlo risks from the FDA, doctors, and the public
Thousands of injured patients and families of deceased patients have already filed GranuFlo lawsuits against Fresenius.
Our Philadelphia Medical Malpractice Lawyers also institute legal claims against physicians who negligently cause their patients’ GranuFlo injuries or deaths. Doctors who do not take adequate care to prevent dangerous reactions to patients’ GranuFlo dialysis treatments can be liable for injuries and deaths caused by GranuFlo.
Contact a Philadelphia GranuFlo Injury Lawyer
You may be entitled to money damages if you suffered personal injuries from GranuFlo. Please contact Feldman & Pinto to learn more about filing a GranuFlo lawsuit. Our personal injury lawyers can help you obtain the compensation and justice you deserve. While a lawsuit cannot restore your health, it can provide compensation for the pain and suffering caused by your exposure to this dangerous product.